Table 1.

Change in Measurements Among Completers

	Median (Q1–Q3)
	Baseline	12 Weeks	P Valuea
Weight, kg	101.6 (85.9–126.7)	100.1 (87.6–127.7)	.55
Height, cm	165.2 (161.2–170.0)	166.4 (161.4–171.0)	.003
BMI, kg/m2	38.1	37.9	.26
Body fat, %	48.7 (35.9–52.0)	46.2 (35.0–51.5)	.0001
Height z score, SD	0.6 (–0.1–1.3)	0.6 (–0.1–1.2)	.85
Weight z score, SD	2.6 (2.1–3.2)	2.5 (2.0–3.2)	.001
BMI z score, SD	2.4 (2.1–2.7)	2.3 (2.1–2.7)	.01
Glucose, mg/dL	80.0 (75.0–88.0)	80.5 (75.0–88.0)	.50
Hematocrit, %	39.5 (36.6–40.8)	37.6 (35.7–40.6)	.11
Hemoglobin, g/dL	13.0 (12.0–13.8)	12.6 (12.1–13.6)	.24
Insulin, µU/mL	11.0 (8.0–17.0)	22.0 (8.0–32.0)	.004
HOMA-IR	2.0 (1.5–3.4)	4.6 (1.4–6.1)	.01
HbA1C, %	5.3 (5.2–5.6)	5.7 (5.5–6.0)	.0001
Vitamin D, ng/mL	14.0 (10.8–17.6)	18.0 (12.9–23.0)	.0001
C-reactive protein, mg/dL	0.4 (0.2–0.6)	0.4 (0.2–0.5)	.45
Homocysteine, µmol/L	7.3 (6.1–9.1)	7.8 (6.3–8.8)	.31
Total cholesterol, mg/dL	159 (142–185)	168 (138–181)	.80
Triglycerides, mg/dL	84 (61–109)	90 (63–114)	.07
HDL, mg/dL	45 (38–50)	43 (38–53)	.75
LDL, mg/dL	98 (73–118)	94 (77–113)	.44

HOMA-IR = (Insulin µU/mL × Glucose mmol/L)/22.5. Glucose mmol/L = Glucose mg/dL × 0.055. BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; LDL, low-density lipoprotein.

^aTesting the null that the median difference is 0.